Revenue
2.81 million USD
2018 Q2 · USD
Exact inputs and evidence
- Revenue: 2808461 USD Source
Fundies. English
Stemcell Holdings, Inc.
EDGAR15 filing records in this dataset, filed from 2016-04-26 to 2018-11-14. Reported financial figures are available; chart coverage varies by period.
Latest quarter
- Cash and cash equivalents
- 4.61 million USD Source
Exact value
4614133 USD
- Long-term debt including current maturities
- Not available
- Shares outstanding
- 27.4 million shares Source
Exact value
27378000 shares
Reported share-count change
-0.79% · -218 thousand shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Revenue
8.11 million USD
2017-07-01 – 2018-06-30
Net income
3.1 million USD
2017-10-01 – 2018-09-30
Exact inputs and evidence
- Net income: 2409694 USD · 2017-01-01 – 2017-12-31 Source
- Net income: 1677154 USD · 2017-01-01 – 2017-09-30 Source
- Net income: 792358 USD · 2018-01-01 – 2018-03-31 Source
- Net income: 1329494 USD · 2018-01-01 – 2018-06-30 Source
- Net income: 792358 USD · 2018-01-01 – 2018-03-31 Source
- Net income: 2366543 USD · 2018-01-01 – 2018-09-30 Source
- Net income: 1329494 USD · 2018-01-01 – 2018-06-30 Source
Operating cash flow
-93.4 thousand USD
2017-10-01 – 2018-09-30
Exact inputs and evidence
- Operating cash flow: -43337 USD · 2017-01-01 – 2017-12-31 Source
- Operating cash flow: 320 USD · 2017-01-01 – 2017-09-30 Source
- Operating cash flow: -922934 USD · 2018-01-01 – 2018-03-31 Source
- Operating cash flow: -49771 USD · 2018-01-01 – 2018-06-30 Source
- Operating cash flow: -922934 USD · 2018-01-01 – 2018-03-31 Source
- Operating cash flow: -49771 USD · 2018-01-01 – 2018-09-30 Source
- Operating cash flow: -49771 USD · 2018-01-01 – 2018-06-30 Source
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2018-11-14.
Financial data available through: 2017-12-31.
Coverage by financial measure
- Revenue: 2 of 11 periods available· newest 2017-12-31
- operating income: No compatible figures in this window
- Net income: 2 of 11 periods available· newest 2017-12-31
- Operating cash flow: 2 of 11 periods available· newest 2017-12-31
- capital expenditure: No compatible figures in this window
- Total assets: 2 of 11 periods available· newest 2017-12-31
- Total liabilities: 2 of 11 periods available· newest 2017-12-31
- Current assets: 2 of 11 periods available· newest 2017-12-31
- Current liabilities: 2 of 11 periods available· newest 2017-12-31
- Cash and cash equivalents: 2 of 11 periods available· newest 2017-12-31
- long term debt: No compatible figures in this window
- Shares outstanding: 2 of 11 periods available· newest 2017-12-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Revenue
+85.1%Prior period
USD 3.34 million
–
Current period
USD 6.18 million
–
Exact inputs and evidence
6179820 − 3338706 = 2841114 USD
3338706 USD · 2016-01-01 – 2016-12-31
Inspect prior input Prior source6179820 USD · 2017-01-01 – 2017-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Net income
+71.8%Prior period
USD 1.4 million
–
Current period
USD 2.41 million
–
Exact inputs and evidence
2409694 − 1402419 = 1007275 USD
1402419 USD · 2016-01-01 – 2016-12-31
Inspect prior input Prior source2409694 USD · 2017-01-01 – 2017-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-162.8%Prior period
USD 69,047
–
Current period
−USD 43,337
–
Exact inputs and evidence
-43337 − 69047 = -112384 USD
69047 USD · 2016-01-01 – 2016-12-31
Inspect prior input Prior source-43337 USD · 2017-01-01 – 2017-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2017 2017-01-01 – 2017-12-31
- Revenue USD 6.18 million 100% of revenue
- Operating costs Derived Unavailable An input is unavailable.
- Operating income Unavailable An input is unavailable.
- Tax, interest and other Derived Unavailable An input is unavailable.
- Net income USD 2.41 million 39% of revenue
Cash
- Operating cash flow −USD 43,337 −0.7% of revenue
- Capital expenditure Unavailable An input is unavailable.
- Free cash flow Derived Unavailable An input is unavailable.
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2016 Not shown: operating income or net income is not reported.
- 2017 Not shown: operating income or net income is not reported.
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2016 2016-01-01 – 2016-12-31 | 3338706 | Unavailable | Unavailable | Unavailable | 1402419 | Unavailable | Source
|
| 2017 2017-01-01 – 2017-12-31 | 6179820 | Unavailable | Unavailable | Unavailable | 2409694 | Unavailable | Source
|
Amounts are exact, in USD.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
USD 6.2M 2017
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Revenue | 3338706 |
|
| 2017 | Revenue | 6179820 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
85.1% 2017
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Year over year | No prior comparable period |
|
| 2017 | Year over year | 85.1% |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Net margin 39% 2017
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016-12-31 | Operating margin | Not reported |
|
| 2017-12-31 | Operating margin | Not reported |
|
| 2016 | Net margin | 42% |
|
| 2017 | Net margin | 39% |
|
| 2016 | Free cash flow margin | Not reported |
|
| 2017 | Free cash flow margin | Not reported |
|
Operating cash flow
Cash generated by the company’s normal business operations.
USD -43.3K 2017
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Operating cash flow | 69047 |
|
| 2017 | Operating cash flow | -43337 |
|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Free cash flow | Unavailable |
|
| 2017 | Free cash flow | Unavailable |
|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
40.7% 2017
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Liabilities / assets | 57.9% |
|
| 2017 | Liabilities / assets | 40.7% |
|
Current assets to current liabilities
Current assets divided by current liabilities.
2.02× 2017
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Current assets / current liabilities | 1.43× |
|
| 2017 | Current assets / current liabilities | 2.02× |
|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2016 2016-01-01 – 2016-12-31 | USD 1.4 million Exact valueExact value: 1402419 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 69,047 Exact valueExact value: 69047 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2017 2017-01-01 – 2017-12-31 | USD 2.41 million Exact valueExact value: 2409694 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 43,337 Exact valueExact value: -43337 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
15 filings · 458 latest values · 458 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001666487, 1666487, edgar:1666487
Also known as Stemcell Holdings, Inc.